Miguel St-Onge

Title: Innovations of Miguel St-Onge

Introduction

Miguel St-Onge is a notable inventor based in Vaudreuil-Dorion, Canada. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that serve as inhibitors for various signaling pathways.

Latest Patents

St-Onge holds two patents that highlight his innovative work. The first patent involves compounds, pharmaceutical compositions, and methods of preparing compounds that act as ATR kinase inhibitors. These compounds are designed for the treatment of subjects in need, specifically targeting the Ataxia-telangiectasia and RAD-3-related protein kinase (ATR). The second patent focuses on imidazopyridazines that are useful as inhibitors of the PAR-2 signaling pathway. This invention encompasses various applications, including methods for treating diseases and disorders, as well as processes for preparing these compounds.

Career Highlights

Throughout his career, Miguel St-Onge has worked with reputable companies such as Repare Therapeutics Inc. and Vertex Pharmaceuticals, Inc. His work in these organizations has contributed to advancements in pharmaceutical research and development.

Collaborations

St-Onge has collaborated with notable coworkers, including Sheldon N Crane and Vouy Linh Truong. These partnerships have likely enhanced his research and innovation efforts.

Conclusion

Miguel St-Onge's contributions to pharmaceutical inventions demonstrate his commitment to advancing medical science. His patents reflect a deep understanding of complex biological pathways and the potential for innovative treatments.